Indian pharmaceutical exports get reprieve from Trump’s reciprocal tariffs
New York, April 3 (IANS) Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House.The US is the largest importer of pharmaceuticals from India, bringing in products in the category worth $8.73 billion during the 2024 fiscal…
Read More...